An analgesic/anti-inflammatory pharmaceutical dosage form which comprises an effective amount of an active ingredient selected from the group consisting of racemic 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, optically active forms thereof and pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable excipient or diluent, said dosage form being an intranasally administrable dosage form.

 
Web www.patentalert.com

< Substituted furo[2,3-g]indazoles for the treatment of glaucoma

> Methods of treating mammals with stabilized particle dispersions containing excipient surface-modified nanoparticles

~ 00490